IDC Health Insights Team
New Research
未来，医疗大数据的发展将进入新的发展阶段。医疗大数据市场的需求由基于政策的要求，向主动化的需求转变。同时，从大型医院向其他医疗卫健机构逐步覆盖；数据主题将从临床、科研等主题，进一步向运营、生信、研发等场景延伸；对于数据的应用加深，从建设基础数据平台建设，到更深层的数据应用场景延展。"医疗大数据的发展正进入新的发展阶段，尽管疫情将这一转变的进程放缓，但市场仍然展现出了活力。外部的政策推动与医院的内部管理需求正促使更广泛的医疗机构对医疗大数据的需求进一步扩增。与此同时，医疗大数据...
This IDC Perspective looks at key developments and news in the European healthcare market in 3Q23."In the third quarter of 2023, European healthcare organizations continued to grapple with persistent challenges, driving deals and investment...
This IDC study discusses how digital transformation accurately characterizes the life science industry's ongoing efforts to transform itself as it seeks to find new paths to innovation, optimize operational efficiency and effectiveness, and...
This IDC Market Presentation provides an IDC Industry Buyers Handbook that aims to help technology vendors understand what drives buyers within the European healthcare industry in their technology purchasing decisions. Vendors can use this ...
This IDC study provides executives across the globe with actionable insights and analysis for future healthcare industry scenarios."The 2024 worldwide healthcare industry predictions show that the industry is at an inflection point, being d...
本IDC研究列出了中国临床试验信息系统主要厂商的市场份额，分析了临床试验信息系统市场的竞争态势，并对领先厂商在2022年的市场表现给予了分析评价，可供医药企业、CRO组织、临床试验研究机构以及生命科学研发机构等在选择临床试验信息系统供应商时参考。“2022年中国临床试验信息系统市场随着中国新药研发的大势而乘势发展，新兴信息化技术的发展为临床试验信息系统产品创新提供了无限的发展动力，互联网、云计算技术广泛应用到系统中，系统也延伸到医院等研究机构，以CTMS和EDC为核心的系统正...
This IDC study provides IDC's top 10 predictions for future of industry ecosystems."The move to more open, extended, pan-industry ecosystems is the next phase of digital transformation. Organizations continue to recognize that innovation is...
This IDC study discusses the top 10 predictions for the life sciences industry for 2024."'Reinvent' is very much the new tagline for the life sciences industry. The 2024 worldwide life sciences industry predictions focus on how the life sci...
中国数字化医药营销解决方案市场研究报告，主要探讨市场环境和发展现状，展望未来发展趋势，阐述多个典型案例，并对厂商生态、竞争格局及主要厂商进行分析，希望借此报告为数字化医药营销领域的最终用户、技术提供商、投资机构提供参考。“尽管疫情已经成为历史，但是疫情对于医药营销的数字化转型的催化作用让市场发展进入了新的阶段。虽然短期内医药营销将受到负面影响，但长期来看，医药营销数字化仍将是大势所趋，数字化营销的占比将稳步提升。未来厂商将进一步完善和丰富医药数字化营销的解决方案，医药营销的效...
This IDC Market Note highlights the progress Oracle has exhibited in several core areas that are central to Oracle's future success. IDC also examines Oracle's recent FY 1Q24 earnings and looks for indications of progress around these key t...
«First | ‹Previous | 161 to 170 of 282 results | Next› | Last»